Qepler

Qepler is a progressive supplier of B2B summits and conferences. We produce events custom made to provide each client with the utmost in professional training.

[Qepler @QEPLERcom]

Join us at the 2nd Annual Drug/Device Combination Products Summit! https://t.co/JVZf4uEUUO

[Qepler @QEPLERcom]

☕ We are starting the 2nd day with Dr. Raphael Krampe | Scientist | Boehringer Ingelheim microParts GmbH sharing his experience in «The Soft Mist Inhaler Respimat® - Performance and test requirements7»
Inhaled Drug Delivery Summit, Berlin, NH Collection…https://t.co/hblSt6egLI

[Qepler @QEPLERcom]

🚩 Finalising the summit with last session «Interactions of Leachables with Biopharmaceuticals: Combined In-Silico and Experimental Model to Monitor the Potential Impact on Quality and Safety of Therapeutic Proteins.» from Ank Reumer, Ph.D. | Study Direct…https://t.co/sxoCOVswFq

[Qepler @QEPLERcom]

🔎 Focusing on «In silico assessment of genotoxic impurities under the ICH M7 guideline (best practice in industry)» with Dr. Joerg Wichard | Pharmaceuticals Division / Genetic Toxicology BLN | Bayer AG at the Genotoxic Impurities in Pharmaceuticals Summi…https://t.co/T0De7iVWKq

[Qepler @QEPLERcom]

👉🏼 Strengthening the knowledge in « Best practice for dealing with conflicting computational predictions for mutagenicity» with Raphael Nudelman, Ph.D., ERT | Director, Chemical & Computational Toxicology | Teva Pharmaceuticals Industries Ltd. Genotoxic…https://t.co/vCQbo9oczn

[Qepler @QEPLERcom]

👨‍🎓 Exploring the «Control of toxic impurities in pharmaceutical products» with Tom van Wijk | Principal Scientist | Abbott Healthcare Products B.V. at the Genotoxic Impurities in Pharmaceuticals Summit 2019, Berlin
#Qepler #QGTI2019 #GTI #Genotoxic #G…https://t.co/RBn6rim5MB

[Qepler @QEPLERcom]

📌 Mike Urquhart | Scientific Director | GSK sharing expertise in «Process Development and impurity control for the PPAR-alpha agonist GW641597X» at the Genotoxic Impurities in Pharmaceuticals Summit 2019, Berlin
#Qepler #QGTI2019 #GTI #Genotoxic #Genot…https://t.co/8jc3CImtCJ

[Qepler @QEPLERcom]

📝 Rodney Parsons | Executive Director, Chemical and Synthesis Development | Bristol-Myers Squibb explaining « Genotoxic Impurity Controls post ICH M7: BMS Work Practices for Assessing and Controlling GTIs»
Genotoxic Impurities in Pharmaceuticals Summit 2…https://t.co/DXI0G2iOJU

[Qepler @QEPLERcom]

Panel discussions. Genotoxic Impurities in Pharmaceuticals Summit, Berlin, RIU PLAZA Berlin
#Qepler #QGTI2019 #GTI #Genotoxic #GenotoxicImpurities #Q3D #ComputationalToxicology #ERT #ADME #AnalyticalChemistry #Chemistry #API #ChemicalToxicology #CMC #Dr…https://t.co/QJr4i2XGZy

[Qepler @QEPLERcom]

💡 Enjoying the session «Strategies for assessment of impurities and E&Ls» from Prof. Dr. Johannes (Hans) Harleman | Vice-President Global Preclinical Development & Management | Fresenius Kabi Deutschland GmbH. Genotoxic Impurities in Pharmaceuticals Sum…https://t.co/pcxhlhAY2e

[Qepler @QEPLERcom]

🔑 Unlocking «What to do if you need to do to propose a regulatory change to a ICH Q3D Elemental Impurity Control
Threshold or PDE Limit» with Lance Smallshaw BSc(Hons) PhD EurChem CSci CChem FRSC | Regulatory Intelligence and External
Advocacy (Quality A…https://t.co/HCLYX113qJ

[Qepler @QEPLERcom]

📌 Anja Slikkerveer, MD, PhD, ERT | Scientific Director Translational Science | Astellas Pharma Europe BV, NL focusing on «ICH Q3D: elemental impurities- an insider’s perspective» at the Genotoxic Impurities in Pharmaceuticals Summit 2019, Berlin
#Qepl…https://t.co/CDo3hnzpxw

[Qepler @QEPLERcom]

🔍Let’s explore «Characterization and quantitation of genotoxic impurities using a single platform. The Valsartan case. » with Axel Besa | Business Development Manager | SCIEX. Genotoxic Impurities in Pharmaceuticals Summit 2019, Berlin
#Qepler #QGTI2019…https://t.co/eMOJZqPcqv

[Qepler @QEPLERcom]

👨‍🎓 Exploring the «ICH M7: Evolution of a Guideline. Has this reached ‘business as usual’?» with Patricia Parris (Ellis) | Project Toxicologist (RIA Safety) |AstraZeneca. Genotoxic Impurities in Pharmaceuticals Summit 2019, Berlin
#Qepler #QGTI2019 #GT…https://t.co/qNmB18Z6Vr

[Qepler @QEPLERcom]

👉 Dr. Lutz Mueller | Toxicology Project Leader – Distinguished Scientist | F. Hoffmann-La Roche Ltd speaking about «Examples of use of ICH M7 in early and late drug development including pediatrics»
at the Genotoxic Impurities in Pharmaceuticals Summit…https://t.co/HIXDyjC3sR

[Qepler @QEPLERcom]

Speed Networking. Genotoxic Impurities in Pharmaceuticals Summit, Berlin, RIU PLAZA Berlin

#Qepler #QGTI2019 #GTI #Genotoxic #GenotoxicImpurities #Q3D #ComputationalToxicology #ERT #ADME #AnalyticalChemistry #Chemistry #API #ChemicalToxicology #CMC #Drug…https://t.co/YSYUUmSWmq

[Qepler @QEPLERcom]

🎯 We are starting the 1st day of the Genotoxic Impurities in Pharmaceuticals Summit, Berlin, RIU PLAZA Berlin
#Qepler #QGTI2019 #GTI #Genotoxic #GenotoxicImpurities #Q3D #ComputationalToxicology #ERT #ADME #AnalyticalChemistry #Chemistry #API #Chemical…https://t.co/TM1RKmq8VJ

[Qepler @QEPLERcom]

🚩 Finalising the summit with last session «Horizon fog testing systems» from Hans-Joachim Jahn | Application Specialist Laboratory Equipment Controlled Temperature Technologies | Thermo Fisher Scientific
#QAG2019 #Qepler #glass #glazing #automotive #auto…https://t.co/4ZMMnGhxQd

[Qepler @QEPLERcom]

🚗 Strengthening the knowledge in «Sunroofs. Defining luxury in a changing market» with Iain Tough | Engineer – Roof Systems | Bentley Motors Ltd. Automotive Glazing Summit 2019, Berlin
#QAG2019 #Qepler #glass #glazing #automotive #autoglass #AutomotiveG…https://t.co/3CDWnDv3zO

[Qepler @QEPLERcom]

👨‍🎓 Exploring the «The Automotive Glazing Technician of the future» with @AutoGlzAcademy | CEO | Automotive Glazing Academy at the Automotive Glazing Summit 2019, Berlin
#QAG2019 #Qepler #glass #glazing #automotive #autoglass #AutomotiveGlazing #AGA #T…https://t.co/E30gX9WK15